Twist Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Twist Bioscience Corp
TWST Stock  USD 40.57  1.77  4.18%   
Twist Bioscience financial statements provide useful quarterly and yearly information to potential Twist Bioscience Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Twist Bioscience financial statements helps investors assess Twist Bioscience's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Twist Bioscience's valuation are summarized below:
Gross Profit
147.2 M
Profit Margin
(0.60)
Market Capitalization
2.5 B
Enterprise Value Revenue
6.6509
Revenue
330.2 M
There are currently one hundred twenty fundamental trend indicators for Twist Bioscience Corp that can be evaluated and compared over time across competition. All traders should double-check Twist Bioscience's current fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

Twist Bioscience Total Revenue

377.92 Million

Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 529.2 K, Net Interest Income of 18.5 M or Interest Income of 18.5 M, as well as many indicators such as Price To Sales Ratio of 9.15, Dividend Yield of 0.0 or PTB Ratio of 5.24. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
  
Check out the analysis of Twist Bioscience Correlation against competitors.

Twist Bioscience Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets478.9 M706.5 M342.9 M
Slightly volatile
Short and Long Term Debt Total92.9 M76.5 M121.4 M
Slightly volatile
Other Current Liabilities21.9 M40.1 M15.2 M
Slightly volatile
Total Current Liabilities49 M81.7 M35.9 M
Slightly volatile
Other Liabilities65.5 K69 K457.2 K
Pretty Stable
Property Plant And Equipment Net98.6 M185.6 M72.7 M
Slightly volatile
Current Deferred Revenue1.8 M1.9 M7.5 M
Very volatile
Accounts Payable1.8 M1.9 M5.8 M
Slightly volatile
Cash200.2 M260.3 M140.1 M
Slightly volatile
Non Current Assets Total157.2 M307.7 M114.9 M
Slightly volatile
Non Currrent Assets Other5.3 M6.8 M3.7 M
Slightly volatile
Long Term Debt1.2 M1.3 M5.6 M
Slightly volatile
Cash And Short Term Investments271.7 M317.9 M193.2 M
Slightly volatile
Net Receivables23.8 M40.1 M16.4 M
Slightly volatile
Good Will103.6 M98.7 M30.8 M
Slightly volatile
Common Stock Shares Outstanding42.5 M66.7 M34.4 M
Slightly volatile
Long Term Debt Total1.2 M1.3 M86.7 M
Slightly volatile
Liabilities And Stockholders Equity478.9 M706.5 M342.9 M
Slightly volatile
Non Current Liabilities Total86.5 M63.6 M115.4 M
Slightly volatile
Capital Surpluse2 B1.9 B698.2 M
Slightly volatile
Inventory19.1 M27.7 M13.1 M
Slightly volatile
Other Current Assets8.9 M13.1 M6.3 M
Slightly volatile
Other Stockholder Equity2.1 B2 B708.8 M
Slightly volatile
Total Liabilities122.2 M127.5 M149.4 M
Pretty Stable
Property Plant And Equipment Gross286.2 M272.5 M94.6 M
Slightly volatile
Short and Long Term Debt1.3 M1.4 M2.2 M
Very volatile
Preferred Stock Total Equity228.9 M334.1 M225 M
Slightly volatile
Total Current Assets321.6 M398.8 M228 M
Slightly volatile
Non Current Liabilities Other444.6 K468.1 K5.4 M
Pretty Stable
Short Term Debt35.8 M34.1 M11.6 M
Slightly volatile
Intangible Assets18.4 M16.6 M12 M
Slightly volatile
Property Plant Equipment258.9 M246.5 M84.6 M
Slightly volatile
Net Working Capital299.8 M317.1 M196.7 M
Slightly volatile
Deferred Long Term Liabilities3 M3.3 M3.6 M
Slightly volatile
Capital Lease Obligations80.7 M97.8 M51.6 M
Slightly volatile

Twist Bioscience Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income18.5 M17.6 M4.8 M
Slightly volatile
Depreciation And Amortization38 M36.1 M12.1 M
Slightly volatile
Interest Expense24.8 K26.1 K581.7 K
Slightly volatile
Selling General Administrative263.7 M251.2 M101.5 M
Slightly volatile
Total Revenue377.9 M359.9 M114.1 M
Slightly volatile
Other Operating Expenses644.6 M613.9 M237.8 M
Slightly volatile
Research Development64 M104.5 M48.9 M
Slightly volatile
Cost Of Revenue216.9 M206.6 M73.7 M
Slightly volatile
Total Operating Expenses427.7 M407.3 M164 M
Slightly volatile
Reconciled Depreciation38 M36.1 M13.4 M
Slightly volatile
Selling And Marketing Expenses2.3 M3.3 M1.8 M
Slightly volatile
Non Recurring18 M20.2 M22.1 M
Slightly volatile

Twist Bioscience Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation61.5 M58.6 M22.3 M
Slightly volatile
Begin Period Cash Flow177.3 M332.7 M132.2 M
Slightly volatile
Other Cashflows From Financing Activities9.3 M9.8 M41.2 M
Slightly volatile
Depreciation38 M36.1 M13.1 M
Slightly volatile
Capital Expenditures5.5 M5.8 M15.3 M
Slightly volatile
Total Cash From Financing Activities7.5 M7.9 M103.5 M
Very volatile
End Period Cash Flow201.5 M263.5 M141 M
Slightly volatile
Change To Netincome99.4 M94.7 M32.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.159.6353.7275
Slightly volatile
Days Sales Outstanding87.8846.8189.7022
Slightly volatile
Stock Based Compensation To Revenue0.240.190.2713
Slightly volatile
Capex To Depreciation0.140.151.5644
Very volatile
EV To Sales8.669.1150.0439
Slightly volatile
Inventory Turnover6.798.586.827
Slightly volatile
Days Of Inventory On Hand58.8144.0362.6452
Slightly volatile
Payables Turnover10499.1824.3995
Slightly volatile
Sales General And Administrative To Revenue0.830.883.7336
Slightly volatile
Research And Ddevelopement To Revenue0.320.333.4006
Slightly volatile
Capex To Revenue0.01770.01871.155
Slightly volatile
Cash Per Share4.64.294.7177
Slightly volatile
Days Payables Outstanding3.623.8159.2773
Slightly volatile
Income Quality0.340.350.7426
Slightly volatile
Intangibles To Total Assets0.150.16330.0677
Slightly volatile
Net Debt To EBITDA0.80.720.7957
Slightly volatile
Current Ratio7.285.626.658
Pretty Stable
Receivables Turnover8.478.074.7986
Slightly volatile
Capex Per Share0.07480.07870.4031
Very volatile
Revenue Per Share5.14.862.0448
Slightly volatile
Interest Debt Per Share0.811.320.897
Slightly volatile
Debt To Assets0.080.120.1155
Slightly volatile
Operating Cycle169103154
Pretty Stable
Days Of Payables Outstanding3.623.8159.2773
Slightly volatile
Ebt Per Ebit1.11.081.0143
Very volatile
Quick Ratio6.935.236.3828
Pretty Stable
Net Income Per E B T1.11.151.0151
Slightly volatile
Cash Ratio3.02.873.5057
Very volatile
Cash Conversion Cycle79.3277.6988.5019
Slightly volatile
Days Of Inventory Outstanding58.8144.0362.6452
Slightly volatile
Days Of Sales Outstanding87.8846.8189.7022
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.971.07921.1665
Very volatile
Fixed Asset Turnover1.11.751.0031
Slightly volatile
Debt Ratio0.080.120.1155
Slightly volatile
Price Sales Ratio9.159.6353.7275
Slightly volatile
Asset Turnover0.480.460.2003
Slightly volatile

Twist Bioscience Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap524.6 M590.2 M643.5 M
Slightly volatile
Enterprise Value493.4 M555.1 M605.2 M
Slightly volatile

Twist Fundamental Market Drivers

Cash And Short Term Investments276.4 M

Twist Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
3rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About Twist Bioscience Financial Statements

Twist Bioscience shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.9 M1.8 M
Total Revenue359.9 M377.9 M
Cost Of Revenue206.6 M216.9 M
Stock Based Compensation To Revenue 0.19  0.24 
Sales General And Administrative To Revenue 0.88  0.83 
Research And Ddevelopement To Revenue 0.33  0.32 
Capex To Revenue 0.02  0.02 
Revenue Per Share 4.86  5.10 
Ebit Per Revenue(0.64)(0.67)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY